| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
X4 Pharmaceuticals Inc (NASDAQ: XFOR)
XFOR Technical Analysis
5
| As on 24th Dec 2024 XFOR STOCK Price closed @ 0.58 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.06 & Strong Sell for SHORT-TERM with Stoploss of 1.42 we also expect STOCK to react on Following IMPORTANT LEVELS. |
XFORSTOCK Price
| Open | 0.58 | Change | Price | % |
| High | 0.62 | 1 Day | 0.00 | 0.00 |
| Low | 0.53 | 1 Week | -0.09 | -13.43 |
| Close | 0.58 | 1 Month | -0.08 | -12.12 |
| Volume | 1805291 | 1 Year | -1.31 | -69.31 |
| 52 Week High 1.90 | 52 Week Low 0.34 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| LMDX | 0.02 | 0.00% |
| LCID | 3.20 | 3.23% |
| AVGR | 1.45 | 126.56% |
| NVDA | 140.22 | 0.39% |
| AKTS | 0.04 | 0.00% |
| TNXP | 0.39 | -2.50% |
| PONO | 1.72 | 2.38% |
| TELL | 1.00 | 0.00% |
| TSLA | 462.28 | 7.36% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| XFOR Daily Charts |
XFOR Intraday Charts |
Whats New @ Bazaartrend |
XFOR Free Analysis |
|
|
XFOR Important Levels Intraday
| RESISTANCE | 0.75 |
| RESISTANCE | 0.70 |
| RESISTANCE | 0.66 |
| RESISTANCE | 0.63 |
| SUPPORT | 0.53 |
| SUPPORT | 0.50 |
| SUPPORT | 0.46 |
| SUPPORT | 0.41 |
XFOR Forecast December 2024
| 4th UP Forecast | 1.31 |
| 3rd UP Forecast | 1.08 |
| 2nd UP Forecast | 0.93 |
| 1st UP Forecast | 0.79 |
| 1st DOWN Forecast | 0.37 |
| 2nd DOWN Forecast | 0.23 |
| 3rd DOWN Forecast | 0.08 |
| 4th DOWN Forecast | -0.15 |
XFOR Weekly Forecast
| 4th UP Forecast | 0.98 |
| 3rd UP Forecast | 0.85 |
| 2nd UP Forecast | 0.77 |
| 1st UP Forecast | 0.69 |
| 1st DOWN Forecast | 0.47 |
| 2nd DOWN Forecast | 0.39 |
| 3rd DOWN Forecast | 0.31 |
| 4th DOWN Forecast | 0.18 |
XFOR Forecast2024
| 4th UP Forecast | 3.76 |
| 3rd UP Forecast | 2.74 |
| 2nd UP Forecast | 2.11 |
| 1st UP Forecast | 1.48 |
| 1st DOWN Forecast | -0.32 |
| 2nd DOWN Forecast | -0.95 |
| 3rd DOWN Forecast | -1.58 |
| 4th DOWN Forecast | -2.6 |
X4 Pharmaceuticals Inc ( NASDAQ USA Symbol : XFOR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
XFOR Business Profile
X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, an oral small molecule antagonist of chemokine receptor CXCR4, which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; Phase Ib clinical trial to treat severe congenital neutropenia and Waldenström macroglobulinemia; and Phase IIa clinical trial for the treatment of clear cell renal cell carcinoma. The company is also developing X4P-002 for the treatment of glioblastoma multiforme; and X4P-003 to treat patients suffering from chronic rare diseases. X4 Pharmaceuticals, Inc. has a license agreement with Abbisko Therapeutics Co., Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications. The company was founded in 2014 and is headquartered in Boston, Massachusetts. Address: 61 North Beacon Street, Boston, MA, United States, 02134
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service